XML 71 R10.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash flows from operating activities:    
Net income $ 22,984 $ 24,537
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and other 112,711 101,168
Share-based compensation expense 4,462 3,279
Bad debt expense 743 485
Gain on sales of real estate, net (152) (11,766)
Impairment 1,655 0
(Gain) loss on extinguishment of debt, net (107) 4,663
Change in fair value of derivative financial instruments 3,079 857
Changes in operating assets and liabilities:    
Receivables and other assets, net (6,021) (4,443)
Accounts payable and accrued liabilities (4,124) 13,212
Security deposits, prepaid rent and other liabilities 3,429 (2,442)
Net cash provided by operating activities 138,659 129,550
Cash flows from investing activities:    
Investments in real estate (253,107) (229,644)
Proceeds from sales of real estate 33,279 40,148
Capital expenditures (17,330) (24,167)
Collection of real estate notes receivable 0 20,000
Restricted cash, escrow deposits and other assets 2,994 (29,318)
Net cash used in investing activities (234,164) (222,981)
Cash flows from financing activities:    
Proceeds from unsecured senior notes 0 297,615
Borrowings on unsecured revolving credit facility 387,000 213,000
Payments on unsecured revolving credit facility (247,000) (233,000)
Borrowings on unsecured term loans 100,000 0
Payments on secured real estate term loan and mortgage loans (76,149) (90,389)
Deferred financing costs (289) (6,093)
Security deposits 145 (1,245)
Proceeds from issuance of common stock, net 44,324 18,016
Repurchase and cancellation of common stock (1,322) (572)
Dividends (108,891) (102,506)
Distributions to noncontrolling interest of limited partners (1,580) (1,061)
Net cash provided by financing activities 96,238 93,765
Net change in cash and cash equivalents 733 334
Cash and cash equivalents - beginning of period 10,413 18,081
Cash and cash equivalents - end of period 11,146 18,415
Healthcare Trust of America Holdings, LP (HTALP)    
Cash flows from operating activities:    
Net income 22,984 24,537
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and other 112,711 101,168
Share-based compensation expense 4,462 3,279
Bad debt expense 743 485
Gain on sales of real estate, net (152) (11,766)
Impairment 1,655 0
(Gain) loss on extinguishment of debt, net (107) 4,663
Change in fair value of derivative financial instruments 3,079 857
Changes in operating assets and liabilities:    
Receivables and other assets, net (6,021) (4,443)
Accounts payable and accrued liabilities (4,124) 13,212
Security deposits, prepaid rent and other liabilities 3,429 (2,442)
Net cash provided by operating activities 138,659 129,550
Cash flows from investing activities:    
Investments in real estate (253,107) (229,644)
Proceeds from sales of real estate 33,279 40,148
Capital expenditures (17,330) (24,167)
Collection of real estate notes receivable 0 20,000
Restricted cash, escrow deposits and other assets 2,994 (29,318)
Net cash used in investing activities (234,164) (222,981)
Cash flows from financing activities:    
Proceeds from unsecured senior notes 0 297,615
Borrowings on unsecured revolving credit facility 387,000 213,000
Payments on unsecured revolving credit facility (247,000) (233,000)
Borrowings on unsecured term loans 100,000 0
Payments on secured real estate term loan and mortgage loans (76,149) (90,389)
Deferred financing costs (289) (6,093)
Security deposits 145 (1,245)
Proceeds from issuance of general partner units, net 44,324 18,016
Repurchase and cancellation of general partner units (1,322) (572)
Distributions to general partner (108,891) (102,506)
Distributions to limited partners and redeemable noncontrolling interests (1,580) (1,061)
Net cash provided by financing activities 96,238 93,765
Net change in cash and cash equivalents 733 334
Cash and cash equivalents - beginning of period 10,413 18,081
Cash and cash equivalents - end of period $ 11,146 $ 18,415